Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.
Rha SY, Castanon E, Gill S, Senellart H, Lopez J, Márquez-Rodas I, Victoria I, Kim TM, Lwin Z, Burger MC, Simonelli M, Cassier PA, Hendifar AE, Ascierto PA, Dutcus C, Okpara CE, Ghori R, Jin F, Groisberg R, Villanueva L.
Rha SY, et al. Among authors: kim tm.
Cancer. 2025 Aug 15;131(16):e70015. doi: 10.1002/cncr.70015.
Cancer. 2025.
PMID: 40808295